Search research articles
Contact Us
Filters
Showing results (131-140 of 349) with videos related to
Page
of 35
Sort By:
European Journal of Heart Failure
|
June 27, 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trial
Luca Monzo, Nicolas Girerd, Kevin Duarte, et al.
European Journal of Heart Failure
|
May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT
João Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.
American Heart Journal
|
December 25, 2015
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials
Josephine Warren, Roxana Mehran, Usman Baber, et al.
European Heart Journal
|
July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
Timothy J Collier, Stuart J Pocock, John J V McMurray, et al.
Circulation. Heart Failure
|
June 15, 2021
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial
João Pedro Ferreira, Zohra Lamiral, John J V McMurray, et al.
Lancet (London, England)
|
September 3, 2020
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, et al.
Clinical Cardiology
|
January 23, 2020
Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia
Yanan Zou, Shuang Yang, Shipeng Wang, et al.
European Journal of Heart Failure
|
April 17, 2023
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation
Gerasimos Filippatos, Dimitrios Farmakis, Javed Butler, et al.
European Journal of Heart Failure
|
May 6, 2020
Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis
David Messika-Zeitoun, Patrick Verta, John Gregson, et al.
European Journal of Heart Failure
|
February 21, 2020
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
Xavier Rossello, João Pedro Ferreira, Stuart J Pocock, et al.
Page
of 35
Search research articles
Search
Showing results (131-140 of 349) with videos related to
Sort By:
Page
of 35
European Journal of Heart Failure
|
June 27, 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trial
Luca Monzo, Nicolas Girerd, Kevin Duarte, et al.
European Journal of Heart Failure
|
May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT
João Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.
American Heart Journal
|
December 25, 2015
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials
Josephine Warren, Roxana Mehran, Usman Baber, et al.
European Heart Journal
|
July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
Timothy J Collier, Stuart J Pocock, John J V McMurray, et al.
Circulation. Heart Failure
|
June 15, 2021
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial
João Pedro Ferreira, Zohra Lamiral, John J V McMurray, et al.
Lancet (London, England)
|
September 3, 2020
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, et al.
Clinical Cardiology
|
January 23, 2020
Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia
Yanan Zou, Shuang Yang, Shipeng Wang, et al.
European Journal of Heart Failure
|
April 17, 2023
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation
Gerasimos Filippatos, Dimitrios Farmakis, Javed Butler, et al.
European Journal of Heart Failure
|
May 6, 2020
Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis
David Messika-Zeitoun, Patrick Verta, John Gregson, et al.
European Journal of Heart Failure
|
February 21, 2020
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
Xavier Rossello, João Pedro Ferreira, Stuart J Pocock, et al.
Page
of 35